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Introduction
After more than one decade of inten-
sive research on nanoscale science 
and nanotechnology (NT) since the 
announcement of National Nanotech-
nology Initiative (NNI) by the US 
Government, the commercialization 
of these NTs is becoming increas-
ingly important. This trend is quite 
natural when the characteristics of 
NT are considered. Applied nano-
science or NT is well known to 
offer great opportunities to the in-
dustries through its ‘disruptive and 
enabling technology’ characteristics. 
The disruptive characteristics signify 
that NT, when it is successfully ap-
plied, can significantly advance or 
even revolutionize the existing tech-
nologies. On the other hand, ‘en-
abling technology’ means that it 
opens up possible ways of many 
things which were impossible in the 
old technology. In the old paradigm, 
the transition from the discovery of 
important results in basic sciences 
into the technological applications 
and commercial exploitations of 
those results took a rather long time. 
But in a new paradigm of recent 
years, where information gathering 
and dissemination became easy 
and fast, such transition has been 
quickened enormously, especially in 
those sectors where NTs are related. 
Moreover, there are many articles 
that claim that NT would give sig-
nificant and broad-ranging impetus 
to the new industrialization. Infact, 
NT-related sectors had been obtain-
ing lots of funds in the last about 
ten years, and people’s expectations 
on NTs are very high. Therefore, 
many people are looking for NT 
commercialization. Actually, success-
ful commercializations of NT have 
already happened or are happen-
ing in various fields. For example, 
nanocatalysts are successfully ap-
plied in a variety of industrial sec-
tors such as petroleum refining and 
water purification (Nanocatalysts, 
2009). According to the report of 
Woodrow Wilson Center (2008), more 
than 1,000 NT-related products are 
already in the market and about 
five NT-related products are coming 
out weekly.
The market size of NT is said to 
have great potential to grow up. Ac-
tually, many funding agencies like 
National Science Foundation in USA 
and market watchers like Cientifica, 
London and Lux Reasearch, New 
York estimate that the potential mar-
ket size will be some trillion US 
dollars in the years around 2010-
2015. However, such predictions can 
not be accurate enough to accept 
due to the broadness of NT–related 
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disciplines and the rapid growth rate 
of NT commercializations. All that 
can be said at this moment is that 
NT market is growing very fast and 
is already substantial.
Even so, NT commercialization has 
not been fast enough up to now to 
appreciate its full potential for vari-
ous reasons. At least, one can say 
that NT commercializations have not 
materialized yet with all the colors 
of the rainbow as predicted by some 
futurists. One reason is that NT 
still lacks some more elaborate pro-
cesses and procedures in provid-
ing nanodevices and nanomachines. 
The other reason might be related 
to the tendency of public reluctance 
in accepting NT in such fields as 
nanomedicine and environmental 
NT. One more reason that we want 
to point out is at least partially 
related to its ‘enabling technology’ 
characteristics not being a direct 
industrial technology such as the 
automobile production technology. 
In this article, we review the ben-
efits from NTs, the characters of 
commercial NT products, various 
barriers to NT commercialization 
and their consequences, and dis-
cuss how to overcome these barriers 




A discussion on the benefits and 
the opportunities of NT would be a 
good starting point to discuss NT 
commercialization. The term ‘nano-
technology’ actually had been used 
in various fields for more than ten 
years by the time when the NNI was 
announced by the US Government. 
For example, the researchers work-
ing on the growth of semiconduc-
tor heterostructures had been using 
this term already in the early nineties 
(Bauer et al., 1986). In this discipline, 
various phenomena such as sharpen-
ing of exciton peak lines and quantum 
Hall effects could be enhanced by 
controlling the composition of the 
hetero-interface at monolayer scale, 
i.e., few nanometer scale. That is, 
nanotechnology ‘enabled’ the prop-
erties that were impossible or dif-
ficult to obtain with old technology 
to newly appear or to be enhanced 
in the materials engineering. Then 
what would be the benefits and op-
portunities that the industries can 
get from the NT? The scientific and 
technological disciplines which can 
benefit from the nanoscaled materi-
als and devices are too numerous to 
mention them all. But, those ben-
efits which are most relevant to this 
question may be classified into three 
categories: i) increased surface-to-
volume ratio benefits, ii) reduced 
particulate mass benefits, and iii) 
quantum benefits, according to the 
origin of functionality enhancement. 
For example, enhanced catalytic 
functionality, reduced particle seg-
regation in organic-inorganic com-
posite materials, and charge mobil-
ity enhancement in low dimensional 
semiconductors fall into categories i), 
ii) and iii), respectively. The benefits 
of nanoscaled structures are based 
on the fact that nanoscale is the 
natural threshold where individual 
atoms or molecules make the tran-
sition to the collective behaviors of 
atoms and molecules. Thus both the 
effects such as quantum and self-
organizing that do not exist in the 
bulk materials and the size-depen-
dent material properties that are 
absent in atoms or molecules can 
be newly exploited by NT. There-
fore, the convergence of NT to the 
relatively new important technolo-
gies such as information technology 
(IT), biotechnology (BT) and environ-
mental technology (ET) may open 
new horizon in the industries of 
these fields.
Now, we ask whether the present 
NT is mature enough to revolutionize 
the old industry or not. The answer 
depends on what we expect from 
Fig.1. Evolution of industrial competitiveness according to the NT adoption. Note that 
the convergence of genuine NTs to other technologies will lead to a jump in the com-
petitiveness of the industries.
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the NTs. Many people say that NT is 
not a simple downscaling of materi-
als but getting new functionality from 
the nanostructured materials, devices 
and machines, and thus replacing 
old technologies. Such concept of 
‘disruptive technology’ characteristics 
is well expressed in Figure 1. Even 
when the properties of nanoparticu-
lates are simply applied to the prod-
ucts of old industry, the functionality 
of the products can be greatly en-
hanced so that the old industry will 
continue its growth for a long time. 
But what we expect to benefit from 
NT is more than that. We want to 
revolutionize the old industry in such 
fields as IT, BT, ET and machinery 
industry by converging NT to these 
technologies. For example, some NT 
researchers imagine nanomachines 
that can clean artery walls. Oth-
ers are developing technologies of 
tagging the antibodies to the nano-
particulate anticancer drugs to exploit 
the active targeting mechanism of the 
antibodies in addition to the passive 
targeting mechanism of anticancer 
drug nanoparticles. When such tech-
nologies are fully developed, medi-
cal industry will be revolutionized 
opening a new medical instrument 
industry and replacing the existing 
chemotherapy drug industries. Such 
convergence of NT to biotechnology 
or medical technology has opened 
new disciplines called nanobiotech-
nology and nanomedicine that are 
expected to revolutionize the life sci-
ence and medical industries. The 
convergence of NT to IT and ET 
also gives or is expected to give a 
new impetus to the IT industries and 
environmental products. For example, 
some water purification plants ex-
ploiting NTs are already in operation 
in the Republic of Korea. Therefore, 
the answer to the question whether 
NT is mature enough to revolution-
ize the industries can be obtained 
by considering the degree of pres-
ent NT commercialization and/or the 
characteristics of NTs appearing in 
the market versus the characteristics 
we expect from NT.
Then how is NT commercialization 
going on? To estimate the degree of 
NT commercialization, another way of 
watching NT research activities and 
related patents in addition to count-
ing NT products, would be helpful. 
Figure 2 shows the status of the world-
wide NT-related research publications 
and patents reported by the OECD 
Working Party on Nanotechnology 
(2008). The fact that patenting activi-
ties as well as research publications 
are increasing more rapidly in recent 
years indicates the notable increase 
of NT commercialization activities in 
recent years through the linkage of 
industry to the NT development. But 
we see in Fig. 2(b) that nanomateri-
als related patents take the largest 
portion followed by the electronic 
devices related ones. Moreover, the 
number of new patents in the field 
of instruments is declining from the 
year 2001, and the patents in the 
nano-machinary and consumer goods 
are extremely rare compared with the 
other fields. These reflect the fact that 
the manufacture of a complex nano-
system such as a nanomachine is 
still at its infancy due to the lack of 
elaborate production processes in the 
hierarchial assembly needed to make 
the complex structures.
Now let’s consider the NT commer-
cialization taking place in the Republic 
of Korea as an example, since the 
country is recognized to be rather 
strong in NT researches (Lux Re-
search, 2007). Figure 3 shows the NT 
competitiveness of various countries 
as of December 2007 studied by Lux 
Research Co. One can easily see that 
the Republic of Korea is classified as 
Fig. 2. The trend of NT research activities in the world. (a) NT-related scientific publication 
and patenting trends. (b) Patenting activities in NT sub-area application fields.
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one of the dominant countries in NT, 
following after USA, Japan and Ger-
many. Moreover, she produces about 
120 world-competing NT products as 
of August 2009 with about 12% share 
of the world NT market (KISTI, 2009). 
This percentage is exceptionally high 
considering the fact that the Republic 
of Korea is a small newly-developed 
country with a rather small domestic 
market. Moreover, the Republic of Ko-
rea is not so strong in terms of basic 
sciences and cutting-edge technolo-
gies. Then how can such strong activi-
ties in the NT researches and commer-
cializations be explained? The answer 
lies in the fact that the Republic of 
Korea has strong industrial technolo-
gies, in such fields as IT, automobile 
production and ship building. Espe-
cially, the Korean IT sector possesses 
an outstanding competitiveness in the 
fields of semiconductor memory de-
vices, cellular phone manufacturing 
and flat panel devices. Also, well-
coordinated efforts of Korean aca-
demia and the government certainly 
helped the development of NTs in 
the Republic of Korea. The Republic 
of Korea is a small country with lim-
ited natural resources that started her 
economic developments after world 
war II, and thus, she had to concen-
trate on the research fields which 
were most relevant to the national 
economic growth. Just after the 
announcement of NNI by the US 
Government, NT was recognized by 
the Korean researchers and the gov-
ernment policy makers to be very 
important for the development of new 
industries insuch fields as robotics, 
energy saving technologies, bio- and 
medical technologies which are cru-
cial in the knowledge-based advanced 
society. Following this recognition, the 
national research institutes were en-
couraged to develop the technologies 
needed to implement NTs to the above-
mentioned technology systems, while 
universities were encouraged to pro-
duce well-trained human resources in 
NT fields.
The existence of strong old indus-
tries is very important for the effec-
tive commercialization of NTs since 
some production companies have to 
be there to accept and to buy the 
newly-developed NTs, even if NT 
‘enabled’ some properties that were 
absent in the old technologies. It 
means that NT is not a technology 
good for the direct production of 
consumer goods. That is, it ‘enables’ 
other technologies. But this does not 
mean that the technology-based start-
up companies are not important. The 
importance of start-up companies and 
business incubation will be discussed 
in the next section. Let us take smart 
materials as an example. The NTs 
can enhance the intrinsic smartness 
of various smart materials such as 
piezoelectric materials, electrostrictive 
or magnetostrictive materials, shape 
memory alloys, electrochromics, and 
even rheological fluids. And smart ma-
terials have many applications in the 
fields of life sciences and healthcare, 
energy, automotive, textiles, aero-
space and aviation. The thing is that 
smart materials are not sold directly 
to the people as consumer goods but 
need some production companies, like 
automobile production company, to 
buy them to be implemented to the 
manufacturing processes of consumer 
goods. Nano-coating technology is an-
other good example. The application 
of this technology to the particles and/
or thin films enhances the smartness 
of existing smart materials to the ex-
treme. But the nano-coated materials 
have to be used in the production of 
consumer goods to be useful. In this 
sense, the existence of strong old 
industries is very important for the 
effective commercialization of NTs. 
Note that the proportion of patents on 
the NT related to consumer goods is 
extremely low in Fig. 2(b). Now, let us 
consider the status of the NT-related 
production in the Republic of Korea. 
Note that all four dominant countries 
in Figure 3 except the Republic of 
Korea, are very strong in basic sci-
ences and in production/cutting-edge 
technologies. That is, they have the 
power to develop both the ‘technology-
Fig. 3. NT competitiveness of various countries in terms of the numbers of research 
papers and patents studied by Lux Research Co. as of December 2007.
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push’ markets and the ‘market-driven’ 
technologies. Thus it is hard to see, 
in these countries, how much the 
production industries are important in 
the NT commercialization. But Korean 
case is different. The Republic of Ko-
rea is chasing them in the NT field 
with her strong production technolo-
gies, although she is not so strong 
in basic sciences and/or cutting-edge 
technologies. Thus the Korean NT 
products may show well the ‘market-
driven’ technology characteristics in 
the NT commercialization.
Figure 4 shows the classification of 
Korean NT products by its sub-areas 
(KISTI, 2009). Korean industries actu-
ally produce 120 different NT products 
as of August 2009. The accumulated 
business cases, counting multiply for 
a same product from different compa-
nies, were reported to be 368 for the 
period from the year 2004 to 2008. 
As can be seen in this figure, nearly 
70% of the Korean NT products are 
in the sub-areas of nanonaterials and 
nanodevices. A survey on the major 
producers of nanodevices (not shown 
here) showed that nearly all of them 
are major electronic companies. And 
the number of US patents in the 
nanoelectronics field registerated by 
the Korean researchers (not shown 
here) is found to have a strong correla-
tion with nanodevice product statistics. 
That is, many of them are registered 
by the major production companies. 
In this respect, the key players in 
the field of Korean nanodevices 
are the major electronic companies 
leading the top-down approach NT. 
Moreover, they are expected to lead 
the field in line with the so-called 
‘Moore’s law’ in the downscaling of 
integrated circuits for at least another 
several years. Although many of other 
patents in the nanodevice sub-area 
were on the electronic devices and 
instruments based on ‘bottom-up’ 
approach, the nanodevice products 
based on the ‘bottom-up’ approach 
are not found in the market. In Korea, 
a lot of research funds and strong 
efforts have been expended towards 
the realization of nanoelectronic de-
vices with carbon nanotubes (CNTs) 
and various semiconductor nanowires 
following the bottom-up approaches. 
Thus the fact that the Republic of Ko-
rea does not have any nanoelectronic 
devices based on the bottom-up ap-
proach in the market means that the 
bottom-up approach to nanoelectronic 
devices is still at its infancy yet to 
be implemented to the manufactur-
ing processes with an accuracy for 
the mass production. This aspect of 
nanodevices will be discussed again 
in the next section. 
Table 1 shows the changes in the 
number of companies manufacturing 
the NT-related products for the years 
2001-2007 under the classification of 
large company, small and medium 
scale enterprise (SME) and venture 
(or start-up) company. When the sur-
vey was started for the first time in 
2001, following the Korea Nanotech-
nology Initiative, 78 companies in total 
were producing NT-related products. 
This number increased to 274 in 2007, 
which amounts to the average annual 
increase rate of 42% for that period. 
The corresponding rate of increase 
for start-up company numbers was 
57%. These huge growth rates indi-
cate that the Korean companies are 
finding good business opportunities in 
the NT-related fields. Active searches 
for the business opportunities in NT 
fields were reflected even in NANO 
KOREA, an annual event of interna-
tional symposium and exhibitions on 
NTs. In NANO KOREA 2009, 149 out 
of 194 exhibitors, i.e., about 76%, from 
nine countries were companies. And 
about 80 percents of the total 7,000 
visitors from 41 countries were NT 
specialists or industry people Most 
of the companies manufacturing 
nanoparticulate products, except 
some cosmetic products related com-
panies, were counted in the catego-
ries of the venture companies and/
or SMEs in Fig. 5. In fact, some of 
the companies in these classes have 
been doing excellent businesses sup-
plying nanoparticulate or mesoscopic 
Table 1: Accumulated number of companies producing nano-related products.
Year 2001 2004 2005 2006 2007
large 45 18 32 32 37
small & medium 28 56 79 92
venture 33 78 126 125 145
Total 78 124 214 236 274
Fig. 4. Number of Korean NT products in the world and domestic markets and the 
percentage of sub-areas.
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particle products to the IT and cos-
metic industries. This means once 
again that their businesses were fa-
cilitated by the existence of production 
industries. The companies belonging 
to nanobiotechnology and nano-fun-
damentals categories i.e., the two 
other parts of Fig. 4, are found to 
be SMEs or venture companies. 
The commercialization of these NT 
sub-areas will be discussed in the 
next section. 
Barriers to the 
nanotechnology 
commercialization
Need of more research 
on	basic	disciplines
A sharp increase of patenting ac-
tivities in recent years observable 
in Fig. 2(a) indicates an increased 
involvement of industries in the NT 
commercialization. However, analysis 
of the patents into sub-areas reveals 
different aspect altogether. We see in 
Fig. 2(b) that about 40% of NT-related 
patents are on nanomaterials. Previ-
ously, we mentioned the fact that most 
of Korean nanoparticulate products 
are used by the existing industries. 
Thus we can safely say that nano-
particles are mostly exploited by the 
existing industries to get the enhanced 
functionality rather than to open revo-
lutionary new industries. This and 
our previous observation that the 
Korean nanodevices are based on 
the top-down approach lead us to 
conclude that the evolutionary in-
dustries, not the revolutionizing new 
industries, are leading current NT 
commercializations.
One of the promising fields to open 
nanoparticle-related new industries in 
near future would be nanobiotechnol-
ogy field. In this field, many studies 
have been carried on the specifically 
designed applications of nanoparticles 
for the diagnostics and treatments of 
various diseases. Perhaps the first 
commercialized nanoparticles used 
in the Korean health care industries 
are those of zinc oxide, titanium diox-
ide and silver. Zinc oxide and titanium 
dioxide nanoparticles are used in cos-
metics and pharmaceutical products 
as the sunscreening ingredients. Silver 
nanoparticles were firstly exploited in 
the Republic of Korea by the washing 
machine manufacturers to enhance 
the antimicrobial functionality of wash-
ing machines. Silver nanoparticles are 
then exploited to manufacture the 
antimicrobial cloths for the wound 
dressings. Other good examples are 
the efforts for the applications of 
gold nanoparticles for the treatments 
of lung cancers and nanoparticulate 
drugs tagged with various antibodies 
or even with T cells for the detection 
of cancers at an early stage. In these 
cases, the impetus to the commercial-
ization of these nanomedical technolo-
gies comes from the expected medical 
safety and the improvement of life 
quality of the patients through the ap-
plication of these technologies as well 
as from the technological advance-
ments. Thus, drug industries and med-
ical science communities are trying to 
accept these new technologies. There-
fore, by the time these technologies 
are completely adopted by medical 
society, many companies producing 
diagnostic and/or chemotherapeutic 
drugs would have been replaced by 
the companies which have adopted 
the production technologies based on 
these principles. In this context, nano-
particle based nanobiotechnology will 
surely revolutionize the old industries 
of the concerned field. But the suc-
cessful commercialization of these 
technologies will depend on so many 
factors such as appropriate transition 
of laboratory technology to production 
technology, existence of appropriate 
manufacturing processes, safety is-
sues in the production processes/
products and investment safety, the 
factors that have not been investigated 
enough so far. 
Needless to say, nanobiotechnology 
has a much wider spectrum than 
nanomedicine, and nanomedicine en-
compasses various fields other than 
simple medical applications of nano-
particles. Moreover, some nanobio-
technologies such as lap-on-a-chip 
have been actively developed by the 
researchers of various life science 
sub-areas as well as by those working 
in nanomedicine. Therefore, let us nar-
row down the scope of our discussion 
to the nanomedicine field, which is 
an entirely new discipline, for a more 
concrete discussion on the Korean 
NT commercialization. Nanomedicine 
might be defined as a field where NTs 
are used to support medical technolo-
gies in such areas as drug delivery, 
nano-sized drugs, in vivo imaging us-
ing NT, NT-assisted in vitro diagnostics 
and biomaterials. Hobson (2009) sug-
gested that nanomedicine might be 
classified into three groups according 
to the innovativeness and develop-
ment generations. He argued that the 
current introduction of NT into medical 
technologies, i.e., the first genera-
tion nanomedicine, was incrementally 
advancing various well-established 
medical fields and could continue for 
many decades. As the technologies of 
the second generation nanomedicine, 
that are currently being discovered 
and developed to overcome foresee-
able barriers to continued progress, 
those NTs for medical use that are 
expected to find mid-term applica-
tions in the form of nanostructures, 
nanodevices, and nanoelectronics are 
mentioned. He suggests that, in the 
third stage, entirely new applications 
that are limited only by the imagination 
and the rate of advancement of NT 
science, are expected to emerge early 
in this century and last well into the 
next one. He also mentioned, as the 
medical disciplines where the NT com-
mercialization is currently occurring, 
those fields of pharmaceuticals, imag-
ing, diagnostics, tissue engineering, 
implant and prosthetics, and medical 
electronics.
The nomenclature ‘nanomedicine’ was 
introduced to the Korean medical 
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society around the year 2000, and it 
was recognized by the policy makers 
as a field with a lot of potential to 
solve many medical science related 
problems through the coordinated re-
searches between NT scientists and 
the medical doctors. Actually, many 
researchers have been working for 
a long time on the above-mentioned 
nanomedicine fields even before the 
term ‘nanomedicine’ was introduced. 
But the status of nanomedicine in-
dustrialization is quite different. Our 
survey shows that the commercializa-
tions of nanomedicine are very limited 
nearly to such fields of drug delivery 
and magnetic resonance imaging. 
That is, the commercial products of 
many nanomedical technologies such 
as tissue engineering products and 
nano-drugs are not in the market al-
though some nanomedicine products 
are in the testing stage. But in the 
cosmetics and drug delivery fields, 
large companies and/or SMEs are 
actively developing the market. In 
general, many nanomedicine fields 
that were mentioned by Hobson as 
fields where commercializations are 
currently occurring, are still at their 
infancy requiring further R&D or in the 
implementation tests to be launched in 
the market. Therefore, it is clear that 
many above-mentioned sub-areas of 
nanomedicine field as well as those 
that were mentioned by Hobson to 
be future technologies, need more 
investigations to be launched in the 
medicine market.
Other fields that need definitely more 
scientific investigations are bottom 
up approach based nanodevices and 
nanomachine fields. As mentioned 
in section 2, nearly all the Korean 
nanodevices that overwhelm the world 
markets are fabricated using the top-
down approach, not a bottom-up ap-
proach. This reflects the fact that i) 
the present bottom-up NTs can not 
provide nanostructures at a produc-
tion scale, monodispersive enough 
needed to control the quantum con-
finement effects, and ii) some mono-
dispersive nanostructures obtained by 
a bottom-up process like colloidal 
quantum dots are not in a stage to 
be implemented in the system level 
for the electronic devices. The only 
commercial devices fabricated by 
the bottom-up approaches that can 
profit from the quantum confinement 
effects were high-brightness LEDs 
and LDs. Even though quantum dot 
infrared photodectors are reported 
to be in the world markets, Korean 
semiconductor industries are not in-
volved in it. Nanomachines fabricat-
ed using the bottom-up approaches 
are not found in the world market 
either. Note that there are little patent-
ing activities in nanomachines field 
as shown in Fig. 2(b). This fact 
means again that a hierarchial as-
sembly technique using a bottom-up 
process that is crucial in the fabrica-
tion of nanomachines is far away 
from the industrial production stage 
due to the lack of appropriate elabo-
rate processes.
In conclusion, for the successful 
commercialization of nanomedicine 
and industrialization of bottom-up 
approach nanodevices and nanoma-
chines, more of basic researches 
especially those related to the hier-
archial assembly are needed to be 
carried out in many of their sub-
areas. Therefore, bottom-up ap-
proaches to nanoscale engineering for 
the devices and machines may re-
quire more interdisciplinary collabo-
rations between physics, chemistry, 
as well as electrical or mechanical 
engineering. In a sense, few decades 
of intensive research and technol-
ogy developments (R&D) may not 
be enough for the full commercializa-
tion of various NTs even in this era 
of new paradigm for the technology 
developments, especially when the 
purposed applications need rather 
complicated nanostructures. In this 
context, it may be interesting to 
study the nature and implementation 
status of the NT-related patents in 
the fields of chemicals, electronics, 
and biotechnology that show above 
average growth rates in Figure 2(b).
Needs	of	 large	 investments
As mentioned in section 2, most 
of Korean companies manufacturing 
nanoparticulate products are start-up 
companies and/or SMEs. This means 
that more often than not these compa-
nies are operating on limited financial 
resources and have rather simple 
engineering processes. However, the 
need of a large investment would be 
a major concern when the products 
to be commercialized are involved 
with the hierarchial assembly tech-
nologies and safety issues, in such 
fields as nanodevices, nanomachines 
and some nanomedicines. Let us 
consider nanomedicine field again. In 
this field, hierarchial assembly tech-
nologies are surely needed if we 
want to manufacture a product that 
can work in the human body with 
the desired complicated functionality. 
And safety issues should be over-
come before the commercialization. 
This means that many engineering 
problems of varying degrees should 
be overcome, and many safety checks 
should be performed at various stages 
to achieve the commercialization of a 
nanomedicine product. A broad survey 
on the status of twenty major Ko-
rean pharmaceutical companies has 
been performed very recently. Ac-
cording to survey results, their weak-
ness comes mainly from the lack of 
large investments and the shortage 
of intellectual properties. They admit-
ted that their competitiveness does 
not exceed about 70% of that of 
multinational biomedical companies. 
On the other hand, they claimed that 
their manpower and technical power 
are strong enough to compete with 
multinational companies. But because 
of the above-mentioned two difficul-
ties, most of Korean pharmaceutical 
companies, except one big company 
which has succeeded in marketing 
some drug delivery products, are try-
ing to secure their futures by focusing 
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their businesses to the manufacturing 
of bio-similar pharmaceutical products 
and trying to expand their business to 
the global market through the M&As. 
Actually all of several Korean pharma-
ceutical companies that have success-
fully developed new drugs had to sell 
their technologies to the competing 
multi-national companies mainly due 
to the difficulties in securing enough 
investments.
As mentioned in section 2, nearly all 
the Korean companies belonging to 
the fields of nanobiotechnology and 
nano-fundamentals shown in Fig. 4 
are start-up companies and/or SMEs. 
They are trying to concentrate their 
businesses, which are mainly based 
on their own high value-added tech-
nologies, in the global market since 
Korean market is rather small. Enough 
funding will be important for their 
competitions in the world market, 
especially when their technologies are 
intended for the medical applications, 
since many complex safety tests over 
a long period of time are needed 
before a new technology or a new 
product can be put in the market. 
Therefore, the business incubation 
for these technologies through ap-
propriate investments is crucial for 
the commercialization of such Korean 
NTs. The problem is that the Korean 
Government can not directly support 
the technology-based start-up com-
panies, since the Republic of Korea 
is a member country of WTO. The 
only way is activating the investment 
markets for the ease of technology-
based start-up companies. Another 
effective way to help the start-up 
companies and/or SMEs is supporting 
their R&D. The growth history of the 
company called ‘Park Systems’ might 
be a good example as a business 
model showing the growth path of a 
technology-based start-up company. 
This company currently belongs to 
SMEs in field of nano-fundamentals in 
Fig. 4. And, its only business item is 
atomic force microscope (AFM). The 
owner of this company has opened 
it in the Republic of Korea in the 
early nineties after coming back from 
the USA. While he was in the USA, 
he had the business experience of 
several years after getting his Ph. D, 
all in AFM-related areas. Although 
other companies manufacturing scan-
ning probe microscopes usually focus 
their businesses on the scientific ap-
plications, he aimed the applications 
of AFM for the industrial as well 
as scientific purposes. He benefited 
from the government R&D funding 
scheme to develop the AFMs suitable 
for the industrial applications. And 
the funding through the investment 
market became easier as the busi-
ness developed further in such way. 
Currently, its world market share of 
the AFM-related products is 7%, 
marking it the second in the world 
after the Veeco Co., a multinational 
company dealing with various high-
valued scientific instruments. About 
70% of its employees are currently 
working on R&D. It is evident that the 
driving force of its growth comes from 
the technological leadership and the 
ensuing easier funding in the invest-
ment market through the enhanced 
competitiveness.
The problem is that such business 
incubation model would not be 
appropriate for the start-up companies 
when they want to commercialize 
a complicated nanostructure in the 
forms of nanomedicines, nanodevices 
or nanomachines where large invest-
ment is necessary. A much larger 
investment will be surely needed es-
pecially when a complicated nano-
structure is aimed for the medical 
applications, where the safety issues 
will surely arise. We mentioned previ-
ously that some Korean pharmaceuti-
cal companies could not finish their 
developments of new drugs because 
of the investment-related difficulties, 
although their company sizes were 
rather big in Korean standard. More-
over, some technologically superior 
Korean start-up companies in the 
field of nanobiotechnology are finding 
it difficult to get the sufficient fund-
ing. The medical product made by 
‘nano-drug’ is another good example 
that needs large investments for the 
commercialization. Nano-drugs are 
reported to be in the stage of devel-
opments. However, the functionality of 
nano-drugs such as pharmaceutical 
effects and any adverse effects or 
even safety in the human body is not 
perfectly proved, since the chemical 
activity of a nanoparticle depends 
on various factors such as chemical 
composition, size and shape. And, in 
general, the study on the toxic effects 
of nano-sized ingredients is still at its 
infancy. Therefore, large investments 
will be surely needed to solve the 
related problems for a long period 
of time. In this context, it can only 
be said that the issue related to the 
large investments in these fields will 
be a big hurdle for developments 




The issue concerning public accep-
tance of NTs or NT products also 
acts as a barrier to the early and easy 
NT commercialization. The public re-
luctance of accepting NT products 
stems mainly from potential harmful 
effects of the free-standing nanostruc-
tures. These days, it is well known 
that the lung diseases caused by 
asbestos are related to its sharp 
shape. Many nanostructures with ex-
tremely high aspect ratio such as 
CNTs and semiconductor nanowires 
are waiting for their applications in 
various fields. However, the study on 
any toxic effects of nanomaterials is 
still at its infancy. For example, the 
toxic effect of CNTs, the most exten-
sively studied nanostructure, is still 
controversial. Unexpected adverse ef-
fects of the nanostructures made by a 
material that is known to be safe in the 
human body are not well investigated 
either. For example, nanoparticle sil-
ver, which is known to be safe in 
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general, may be accumulated in the 
kidney when they are inhaled through 
the respiratory system, even though 
any symptom related to such accumu-
lation is not reported yet (Sung et al., 
2009). In general, the adverse effects 
of free-standing nanomaterials are not 
well-studied. This might be partially re-
lated to the fact that a systematic study 
on this subject needs an investigation 
of wide spectrum over a long period 
of time, since the chemical activity 
of a nanostructure depends on such 
wide factors as chemical composition, 
size, mass, surface area, and shape. 
The public concern is based on the 
fact that they do not have accurate 
and enough information on this sub-
ject. Thus a vague knowledge or 
ignorance of this subject leads the 
public to a vague fear on NT and 
NT products.
Therefore, our major concern is how 
we may overcome such public reluc-
tance reasonably. What we should 
do first is to conduct scientific and 
systematic investigations on potential 
toxic effects of nanostructures. With-
out such results, we cannot persuade 
the public. Secondly, we should estab-
lish a world-wide system or network 
to gather and disseminate such infor-
mation. Although the Woodrow Wilson 
Center in USA is believed to do such 
a mission partially, the networking 
of such institutes is needed so that 
the work of extremely wide spectrum 
could be conducted harmoniously. 
Lastly, the scientists and other opin-
ion leaders should persuade actively 
the public about the benefits and 
potential risks with the obtained sci-
entific knowledge. Usually, scientists 
do not willingly involve themselves in 
public engagements, even though they 
enjoy to explain their ideas to their 
peers. However, we need to remember 
the case of genetically modified foods 
where a fear on the potential effects 
is the main barrier to the commercial-
ization. The future of the commercial-
ization of some NT products would 
not be guaranteed if the public is 
not persuaded on the fact that their 
potential adverse effects can be 
avoided following the prescribed user 
manual, even if they can provide 
many benefits.
In a sense, many disruptive tech-
nologies in our history had confronted 
backlashes from the public and/or 
the stakeholders. For example, in 
the early years of eighteenth century, 
many people were against the con-
struction of railway system in England 
when Stephenson was developing lo-
comotives and constructing railroads 
(Smiles, 1857). The construction of 
nuclear power plants is still suffer-
ing opponent public opinions be-
cause of the doubt on the security 
assurance. Nanotechnology surely 
has the nature of disruptive technol-
ogy in wide application fields. And, 
the public tend to accept it, as we 
see in the nanomedicine field 
(Berube, 2009), because of its huge 
potential benefits. But the public 
will be reluctant to accept them 
unless their security to the human 
body is assured in an appropriate 
way in near future. Such public 
reluctance will surely act as a barrier 
to their early and easy commercial-
ization. 
Summary
Many commercial NT products have 
innovative characteristics rather than 
the disruptive ones. But some NT 
products with a simple structure and 
disruptive characteristics are being 
exploited by the production indus-
tries to enhance or to enable the 
desired functionality. In this aspect, 
the existence of strong production 
industries makes the commercializa-
tion of some simple nanostructures 
easy. Nanodevices, nanomachines or 
nearly all of nanomedicines with a 
complicated structure manufactured 
by the bottom-up approach are not 
in the market yet. This is surely 
due to the engineering difficulties of 
hierarchial assembly in the present 
NTs. In this context, more researches 
in the basic disciplines, especially 
the interdisciplinary ones, are des-
perately needed. The needs of 
large investments and the issues on 
the public acceptance of nanotech-
nology are believed to be another 
barrier to the successful commer-
cialization of some nanotechnology 
products.
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